Resources
About Us
Meticulous Research®—a leading market research company, published a research report titled ‘Ultrasound Transducers Market by Product (Convex, Linear, Endocavitary, Phased Array, CW Doppler), Application (Diagnostic [Cardiovascular, OB/GYN, Musculoskeletal), Therapeutic), End User (Hospitals, Diagnostic Centers, ASC) - Global Forecast to 2030”.
According to this latest publication from Meticulous Research®, the ultrasound transducers market is projected to reach $5.5 billion by 2030, at a CAGR of 5.4% from 2024 to 2030. The rising prevalence of cardiovascular and abdominal disorders, technological developments in ultrasound, growing incidences of orthopedic injuries and musculoskeletal disorders, the rising geriatric population, and the increasing number of hospitals are the factors contributing to the growth of this market. Additionally, the emergence of POC ultrasound devices and emerging economies are expected to offer significant growth opportunities for the players operating in the ultrasound transducers market.
COVID-19 Pandemic Impact on the Ultrasound Transducers Market
During the COVID-19 pandemic, imaging procedures were the essential component of care for patients with symptoms. Besides computed tomography (CT) and X-ray imaging, lung ultrasound (LUS) has become an emerging tool for assessing COVID-19 patients. LUS was used at the bedside as point-of-care ultrasound (PoCUS). Hence it was possible to examine the emergency department. Care against contamination was the main priority during the examination in healthcare settings. In such a case, the wireless ultrasound probe and the portable console were in a sterile cover. Subsequently, the probe and the console were disinfected and again put in a sterile cover after use.
The utility of lung ultrasound in COVID-19 involved many factors, including the patient’s clinical presentation, the provider’s practice environment, their access to resources & testing, expertise, experience, current epidemiological trends, healthcare system capacity, and infection transmission risk. Also, computer vision software, artificial intelligence, computer automation and quantification, telemedicine and other methods were researched and developed to study lung ultrasound optimization within and beyond the SARS-CoV-2 pandemic. Hence, the pleural and lung ultrasound were the alternative diagnostic test to assess the degree of involvement of the lung parenchyma by evaluating specific ultrasound patterns, identification of pleural effusions, and barotrauma.
However, due to the global focus on preventing the spread of COVID-19 infections, the use of ultrasound for other applications declined to some extent as patients were restricted in healthcare settings. But, post-pandemic, the demand for ultrasound procedures reached pre-pandemic levels as all the treatments and diagnoses resumed.
The ultrasound transducers market is segmented by Product (Convex, Linear, Endocavitary, Phased Array, CW Doppler, Others), Application (Diagnostic [Cardiovascular, General Imaging, Orthopedic & Musculoskeletal, Obstetrics & Gynecology (OB-GYN), Other Applications] and Therapeutic), End User (Hospitals & Clinics, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Other End Users), and Geography. The study also evaluates industry competitors and analyzes the regional and country-level markets.
Based on product, in 2024, the convex segment is expected to account for the largest share of the ultrasound transducers market. Factors contributing to the large share of this segment are its high efficiency in focusing on deeper organs compared to other transducers. It offers a wider footprint than linear-array configuration and focuses on the deep part of the targeted region. It also displays a clearer picture with highly improved reliability. These factors are anticipated to fuel the demand for a convex scanning transducer.
Based on application, in 2024, the diagnostics segment is expected to account for the largest share of the ultrasound transducers market. The large market share of this segment is attributed to the high demand for radiation-free and non-invasive diagnostic modalities for testing various disorders, including cardiovascular, orthopedic, and musculoskeletal, among others.
Based on end user, the ultrasound transducers market is segmented into hospitals & clinics, diagnostic imaging centers, ambulatory surgical centers, and other end users. In 2024, the hospitals & clinics segment is expected to account for the largest share of the ultrasound transducers market. Owing to the high adoption of ultrasound systems as the primary imaging option. The availability of portable ultrasound systems and the usage of this modality in each department is anticipated to boost the demand for ultrasound transducers. The rising number of healthcare facilities in emerging economies is one of the major demand drivers for ultrasound transducers. An increasing number of skilled professionals in hospitals and growing awareness regarding innovative devices are a few other driving factors affecting segment growth.
This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe), Asia-Pacific (China, Japan, India, and RoAPAC), Latin America (Brazil, Mexico, and RoLATAM), and the Middle East & Africa. In 2024, North America is expected to account for the largest share of the ultrasound transducers market, followed by Europe and Asia-Pacific. High demand for minimally invasive surgery, high incidence of chronic and lifestyle-related disorders, and technological advancements in ultrasound technology are the major factors responsible for the largest share of the region.
Key Players
The key players operating in the ultrasound transducers market are GE Healthcare (U.S.), Seimens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), FUJIFILM Sonosite, Inc. (U.S.), Canon Medical Systems Corporation (Japan), Hitachi Medical Corporation (Japan), Samsung Medison Co., Ltd. (South Korea), Esaote SpA (Italy), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Carestream Health, Inc (U.S.), and ALPINION MEDICAL SYSTEMS Co., Ltd. (South Korea).
Download PDF Brochure @ https://www.meticulousresearch.com/download-sample-report/cp_id=5401
Key questions answered in the report-
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Bakuchiol Serum Market to Reach $4.41 Million by 2031
Read MoreBurn Care Market to be Worth $4.32 Billion by 2031
Read MoreAfrica Medical Devices Market to be Worth $7.14 Billion by 2031
Read MoreMiddle East Medical Devices Market to be Worth $8.8 Billion by 2031
Read MoreSurgical Drills Market to be Worth $1.71 Billion by 2031
Read MoreTissue Engineering Market to reach $7.41 Billion by 2031
Read MoreDental Prosthetics Market to be Worth $ 19.6 Billion by 2031
Read MoreIVD Assay Development Market to be Worth $8.39 Billion by 2031
Read MoreNeurogenomics Market to Reach $4.68 Billion by 2031
Read MoreIndia VNA & PACS Market to Reach $341.6 Million by 2031
Read MoreChina Microarray Market to Be Worth $910.4 Million by 2031
Read MoreChina Neurogenomics Market to Reach $562.1 Million by 2031
Read MoreELISA Market to be Worth $32.69 Billion by 2031
Read MoreDNA Sequencing Market to be Worth $21.30 Billion by 2031
Read MoreOral Care Market to be Worth $58.99 Billion by 2031
Read MoreSpirometer Market to be Worth $1.80 Billion by 2031
Read MorePet Care Market to be Worth $287.96 Billion by 2031
Read MoreRegenerative Medicine Market to be Worth $37.27 Billion by 2031
Read MoreHemostats Market to be Worth $5.32 Billion by 2031
Read MoreBioreactors Market to be Worth $39.96 Billion by 2031
Read MoreProtein Assays Market to be Worth $4.36 Billion by 2031
Read MoreVeterinary API Market to Reach $15.84 Billion by 2031
Read MoreAsia-Pacific NGS Automation Market to be Worth $371 Million by 2031
Read MoreLatin America NGS Market to be Worth $765.2 Million by 2031
Read MoreBiochemical Reagents Market to be Worth $39.61 Billion by 2031
Read MoreMicroarray Kits Market to be Worth $2.51 Billion by 2031
Read MoreAntibody Production Market to Reach $58.35 Billion by 2031
Read MoreMiddle East IVD Market to be Worth $2.15 Billion by 2031
Read MoreSpatial Genomics Market to be Worth $3.23 Billion by 2031
Read MoreAsia-Pacific IVD Market to be Worth $36.02 Billion by 2031
Read MoreEurope NGS Market to be Worth $6.40 Billion by 2030
Read MoreLab Automation Market to be Worth $11.31 Billion by 2031
Read MoreBioinformatics Market to Reach $31.71 Billion by 2031
Read MoreEurope IVD Market to be Worth $39.77 Billion by 2030
Read MoreSequencing Kits Market to be Worth $25.29 Billion by 2031
Read MoreVeterinary API Market to Reach $15.84 Billion by 2031
Read MoreU.S. Ambulatory EHR Market to be Worth $3.97 Billion by 2031
Read MoreSample Preparation Market to be Worth $12.77 Billion by 2031
Read MoreSurgical Robots Market Worth $25.47 Billion by 2030
Read MoreMedical Coatings Market Worth $3.32 Billion by 2030
Read MoreDigital Therapeutics Market to be Worth $56.34 Billion by 2031
Read MoreLiquid Handling Systems Market Worth $6.99 Billion by 2029
Read MoreElectrosurgery Market to be Worth $8.99 Billion by 2031
Read MoreRadiation Dose Management Market Worth $749.1 Million by 2029
Read MoreMolecular Diagnostics Market Worth $46.69 Billion by 2030
Read MoreNewborn Screening Market to be Worth $2.69 Billion by 2031
Read MorePharmacogenomics Market to be Worth $19.5 Billion by 2031
Read MoreDental Practice Management Software Market Worth $ 3.11 Billion by 2029
Read MoreNepal IVD Market Worth $62.7 Million by 2029
Read MorePharmaceutical Contract Packaging Market Worth $42.03 Billion by 2029
Read MoreIndonesia IVD Market Worth $1.11 Billion by 2029
Read MoreMedical Waste Management Market Worth $17.02 billion by 2030
Read MoreEmpty Capsules Market Worth $4.47 Billion by 2029
Read MoreClear Aligners Market to be worth $18.8 Billion by 2030
Read MoreHLA Typing Market Worth $1.9 Billion by 2029
Read MoreReal-world Data Market Worth $1.66 billion by 2029
Read MoreTrack and Trace Solutions Market Worth $27.27 billion by 2029
Read MoreSurface Disinfectant Market Worth $9.52 Billion by 2029
Read MoreElectronic Lab Notebook Market Worth $787.7 million by 2029
Read MoreRapid Diagnostics Market to be Worth $22.65 Billion By 2031
Read MorePlasma Therapy Market Worth $882.5 Million by 2028
Read MorePeripheral Vascular Devices Market Worth $12.02 Billion by 2028
Read MoreBiomaterials Market to Reach 128.7 Billion USD by 2023
Read MoreVaccine Storage Equipment Market Worth $1.83 billion by 2027
Read MorePlasma Fractionation Market Worth $46.9 Billion by 2029
Read MoreHome Healthcare Market to be Worth $514.5 Billion by 2030
Read MoreCardiac Pacemaker Devices Market Worth $4.34 Billion by 2028
Read MoreEuropean Laboratory Informatics Market Worth $1,084.3 Million By 2024
Read MoreCompetent Cells Market Worth 2,318.6 Million USD By 2023
Read MoreCancer Immunotherapy Market to be Worth $267.2 Billion by 2030
Read MoreMultimodal Imaging Market Worth $1.6 Billion By 2024
Read MorePulse Lavage Market to be Worth $661.1 Million by 2030
Read MoreMedical Cooling Systems Market Worth $2.8 Billion By 2024
Read MoreTissue Diagnostics Market Worth $8.52 Billion by 2029
Read MoreEndoscopy Equipment Market Worth $59.8 Billion by 2029
Read MoreAfrican Forensic DNA Testing Market Worth $136.3 Million by 2025
Read MoreClinical Trial Supplies Market to be Worth $5.59 Billion by 2031
Read MoreInfection Control Market Worth $58.2 Billion by 2027
Read MoreSleep Apnea Devices Market Worth $12.9 billion by 2027
Read MoreMedical 3D Printing Market To Reach $983.2 Million By 2020
Read MoreGenomics Market to be Worth $70.52 Billion by 2031
Read MoreAnalytical Standards Market Worth $2.66 Billion By 2027
Read MoreTelehealth Market Worth $539.73 Billion by 2029
Read MoreCell Culture Market Worth $48.63 Billion by 2029
Read MoreAntimicrobial Coatings Market to be Worth $12.41 Billion by 2031
Read MoreFlow Cytometry Market Worth $6.4 Billion by 2027
Read MoreMedical Aesthetics Market Worth $29.43 billion by 2029
Read MoreOligonucleotide Synthesis Market Worth $3.9 Billion by 2025
Read MoreIn Vitro Diagnostics Market to be Worth $116.28 Billion by 2031
Read MoreDental Implants Market Worth $6.52 Billion by 2029
Read MoreActive Implantable Devices Market Worth 24.02 Billion USD By 2022
Read MoreVentilators Market to be Worth $13.23 Billion by 2031
Read MoreDialysis Market to be Worth $36.6 Billion by 2031
Read MorePlasmapheresis Market to be Worth $2.55 Billion by 2030
Read MoreDiabetes Care Devices Market Worth $31.9 Billion by 2028
Read MoreClinical Genomics Market Worth 879.0 Million USD By 2023
Read MoreIVD Quality Control Market to be Worth $2.28 Billion by 2031
Read MoreLaboratory Informatics Market Worth $6.1 Billion by 2030
Read MoreChromatography Data Systems Market to be Worth $1.7 billion by 2030
Read MoreBone Growth Stimulators Market Worth $1.94 Billion by 2030
Read MoreDigital Diabetes Market worth $12.03 billion by 2025
Read MoreTrocars Market Worth $968.5 Million by 2024
Read MoreHealthcare Virtual Assistant Market Worth $1.76 Billion By 2025
Read MoreEurope Hospital Beds Market to be Worth $2.09 Billion by 2030
Read MoreImmunoassay Market Worth $46.49 Billion by 2028
Read MoreHospital Beds Market to Reach $7.09 Billion by 2031
Read MoreUrinalysis Market Worth $2.19 billion by 2027
Read MoreMedical Image Management Market Worth $7.22 billion by 2030
Read MoreBreast Imaging Market Worth $7.08 Billion by 2027
Read MoreVNA & PACS Market to be Worth $6.50 Billion by 2031
Read More